�鶹Ů��

A medical cures bill is in jeopardy following congressional Democrats’ push for it to address high drug prices. A coalition of liberal groups has come out against passage of the measure this year, further putting its future in doubt.  A spokesperson for Democrats on the House Energy and Commerce Committee released a statement Thursday saying the bill, known as 21st Century Cures, “must include” policies to address high drug prices, raising questions about whether Republicans would agree to such additions and help pass the bill this year. (Sullivan, 10/27)

House Democrats aren’t ruling out advancing medical innovation legislation before the end of the year after about a dozen left-learning groups this week urged them to delay the bill. “We continue to work closely with our Republican and Senate counterparts to find a way to proceed with a final Cures bill that Democrats can support,” a Democratic spokesman for the Energy and Commerce Committee said. “Any final bill must include policies that facilitate access to affordable drugs and do not exacerbate rising drug prices in this country while also allowing for innovation to help treat diseases.” “The final bill also must include Democratic funding priorities like the Vice President’s Cancer Moonshot program,” the spokesman added. (McIntire, 10/27)